- Report
- March 2024
- 182 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 187 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- May 2024
- 356 Pages
Global
From €5265EUR$5,450USD£4,502GBP
- Report
- November 2023
- 148 Pages
Global
From €2414EUR$2,499USD£2,064GBP
- Report
- August 2023
- 122 Pages
Global
From €5313EUR$5,500USD£4,543GBP
- Report
- February 2024
- 137 Pages
Global
From €4588EUR$4,750USD£3,923GBP
- Clinical Trials
- April 2024
- 180 Pages
Global
From €2415EUR$2,500USD£2,065GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1932EUR$2,000USD£1,652GBP
- Report
- September 2023
- 79 Pages
Global
From €6757EUR$6,995USD£5,778GBP
- Report
- July 2018
- 15 Pages
Global
- Report
- January 2022
- 60 Pages
Global
From €3816EUR$3,950USD£3,263GBP
- Report
- January 2022
- 200 Pages
Global
From €7245EUR$7,500USD£6,195GBP
- Report
- January 2022
- 60 Pages
Global
From €3816EUR$3,950USD£3,263GBP
- Report
- January 2022
- 60 Pages
Global
From €3816EUR$3,950USD£3,263GBP
- Report
- August 2022
- 118 Pages
Global
From €4347EUR$4,500USD£3,717GBP
- Report
- August 2022
Global
From €1149EUR$1,190USD£983GBP
- Report
- August 2022
United States
From €1874EUR$1,940USD£1,602GBP
- Report
- August 2021
Europe
From €3304EUR$3,420USD£2,825GBP
- Report
- August 2021
Global
From €3854EUR$3,990USD£3,296GBP
- Report
- June 2020
- 37 Pages
Global
From €3859EUR$3,995USD£3,300GBP
Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. It is the most common type of acute leukemia in adults. Treatment for AML typically involves chemotherapy, radiation therapy, and stem cell transplantation. Drugs used to treat AML include cytarabine, daunorubicin, and idarubicin. These drugs are used to kill cancer cells, reduce the size of tumors, and reduce the risk of relapse. Other drugs used to treat AML include decitabine, gemtuzumab ozogamicin, and venetoclax. These drugs are used to target specific genetic mutations that are associated with AML.
The AML drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Novartis, Pfizer, Celgene, Bristol-Myers Squibb, and Merck. Other companies in the market include AbbVie, AstraZeneca, Johnson & Johnson, and Sanofi. Show Less Read more